SCHEMBL1484508

SCHEMBL1484508

C#CCS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687901 0.72 CA2 (0.32)
SCHEMBL18672264 0.72
SCHEMBL3411438 0.71
SCHEMBL5574470 0.69
SCHEMBL1109972 0.69
SCHEMBL208235 0.69
SCHEMBL3474802 0.69
SCHEMBL3307131 0.67
SCHEMBL3302505 0.67
SCHEMBL5575565 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3674298-B9 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS Bayer Pharma AG (DE) 2024-06-19 EP claimed
EP-3674298-B1 SUBSTITUTED INDAZOLES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS CONTAINING THEM, AND THEIR USE FOR THE PREPARATION OF MEDICAMENTS Bayer Pharma AG (DE) 2024-01-10 EP claimed
CN-113131000-B Carbonate electrolyte and metal lithium battery 清华大学深圳国际研究生院 2022-11-22 CN claimed
EP-3464266-B1 SUBSTITUTED INDAZOLES USEFUL FOR TREATMENT AND PREVENTION OF ALLERGIC AND/OR INFLAMMATORY DISEASES IN ANIMALS BAYER ANIMAL HEALTH GMBH (DE) 2021-10-20 EP claimed
CN-113131000-A Carbonate electrolyte and metal lithium battery 清华大学深圳国际研究生院 2021-07-16 CN claimed
US-20190036170-A1 ELECTROLYTES CONTAINING SUPERHALOGENS FOR METAL ION BATTERIES UNITED STATES DEPARTMENT OF ENERGY 2019-01-31 US claimed
EP-3099685-B1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2018-04-18 EP claimed
EP-2958928-B1 ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3) Bayer Pharma AG (DE) 2018-03-28 EP claimed
US-20170250444-A1 HALOGEN-FREE ELECTROLYTES UNITED STATES DEPARTMENT OF ENERGY 2017-08-31 US claimed
EP-2872502-B1 NOVEL INDAZOLES FOR THE TREATMENT AND PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2016-08-24 EP claimed
EP-1492536-B1 4-(N-PHENYLAMINO)-QUINAZOLINES / QUINOLINES AS TYROSINE KINASE INHIBITORS BOEHRINGER INGELHEIM PHARMA (DE) 2012-05-09 EP claimed
US-20110281177-A1 NONAQUEOUS ELECTROLYTE SOLVENTS AND ADDITIVES US GOVERNMENT AS REPRESENTED BY SECRETARY OF THE ARMY (US) 2011-11-17 US claimed
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP claimed
EP-1567499-B1 SUBSTITUTED PYRIDYLOXYALKYLAMIDES AND THEIR USE AS FUNGICIDES SYNGENTA LTD (GB) 2008-11-05 EP claimed
EP-1567480-B1 N-ALKYNYL-2-(SUBSTITUTED PHENOXY) ALKYLAMIDES AND THEIR USE AS FUNGICIDES SYNGENTA LTD (GB) 2008-03-12 EP claimed
EP-1567010-B1 QUINOLIN-, ISOQUINOLIN-, AND QUINAZOLIN-OXYALKYLAMIDES AND THEIR USE AS FUNGICIDES SYNGENTA LTD (GB) 2007-10-24 EP claimed
EP-1005470-B1 OXINDOLYLQUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2007-08-01 EP claimed
EP-1379577-B1 CONTROLLING SOLAR RADIATION IN SAFETY GLASS LAMINATES SOLUTIA INC (US) 2004-08-25 EP claimed
EP-0912557-B1 OXINDOLE DERIVATIVES ASTRAZENECA AB (SE) 2003-07-09 EP claimed
EP-0737722-B1 New indoaniline metal complex, process for their production, and transparent recording medium and optical recording medium by use thereof JUJO PAPER CO LTD (JP) 2001-07-04 EP claimed